Drug Shortage Report for TALTZ

Last updated on 2025-03-01 History
Report ID 250993
Drug Identification Number 02455102
Brand name TALTZ
Common or Proper name ixekizumab
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) IXEKIZUMAB
Strength(s) 80MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1 mL single-dose prefilled autoinjector
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2025-02-18
Estimated end date 2025-03-03
Actual end date 2025-02-28
Shortage status Resolved
Updated date 2025-03-01
Company comments The estimated end date represents projected availability at the main Lilly warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their distributor to obtain information on stock status. In the event you are unable to source supply of the Taltz 80 mg prefilled autoinjector and for any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). Taltz 80 mg prefilled syringe format (DIN 02455110) is not impacted.
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-03-01 English Compare
v4 2025-02-28 French Compare
v3 2025-02-28 English Compare
v2 2025-02-21 French Compare
v1 2025-02-21 English Compare

Showing 1 to 5 of 5